Benefits and harms vary among atypical antipsychotic medications for off-label use. For global behavioral symptom scores associated with dementia in elderly patients, small but statistically significant benefits were observed for aripiprazole, olanzapine, and risperidone. Quetiapine was associated with benefits in the treatment of generalized anxiety disorder, and risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; however, adverse events were common.

Atomically thin, single-crystalline InVO 4 sheets with the uniform thickness of ∼1.5 nm were convincingly synthesized, which was identified with strong, low-angle X-ray diffraction peaks. The InVO 4 atomic layer corresponding to 3 unit cells along [110] orientation exhibits highly selective and efficient photocatalytic conversion of CO 2 into CO in the presence of water vapor. Surface potential change measurement and liquid photoluminescence decay spectra confirm that the atomically ultrathin structure can shorten the transfer distance of charge carriers from the interior onto the surface and decrease the recombination in body. It thus allows more electrons to survive and accumulate on the surface, which is beneficial for activation and reduction of CO 2 . In addition, exclusively exposed {110} facet of the InVO 4 atomic layer was found to bind the generating CO weakly, facilitating quick desorption from the catalyst surface to form free CO molecules, which provides an ideal platform to catalytically selective CO product.

Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant differences in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of ROS-related diseases. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, with applications to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive moieties, the self-immolative linkers, and the typical activation mechanism for the ROS-responsive release are also summarized and discussed.